Index by Author

June 2005; 5 (3)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

C

  1. Chen, Billy

    • The Cardiotoxicology of Anthracycline Chemotherapeutics: TRANSLATING MOLECULAR MECHANISM INTO PREVENTATIVE MEDICINE Mol Interv June 2005 5:163-171; doi:10.1124/mi.5.3.6

  2. Chen, Jiyun

    • Discovery and Therapeutic Promise of Selective Androgen Receptor Modulators Mol Interv June 2005 5:173-188; doi:10.1124/mi.5.3.7

  3. Collinge, Dan

    • Lead to Gold: The Transmutation of Alchemy Mol Interv June 2005 5:189-190; doi:10.1124/mi.5.3.8

D

  1. Dalton, James T.

    • Discovery and Therapeutic Promise of Selective Androgen Receptor Modulators Mol Interv June 2005 5:173-188; doi:10.1124/mi.5.3.7

G

  1. George, Susan R.

    • A G Protein–Coupled Receptor For Estrogen: The End Of The Search? Mol Interv June 2005 5:158-161; doi:10.1124/mi.5.3.5

H

  1. Hasbi, Ahmed

    • A G Protein–Coupled Receptor For Estrogen: The End Of The Search? Mol Interv June 2005 5:158-161; doi:10.1124/mi.5.3.5

K

  1. Kharasch, Evan D.

    • CYP3A Probes Can Quantitatively Predict the In Vivo Kinetics of Other CYP3A Substrates and Can Accurately Assess CYP3A Induction and Inhibition Mol Interv June 2005 5:151-153; doi:10.1124/mi.5.3.3

  2. Kim, Juhyun

    • Discovery and Therapeutic Promise of Selective Androgen Receptor Modulators Mol Interv June 2005 5:173-188; doi:10.1124/mi.5.3.7

L

  1. Lim, Chee Chew

    • The Cardiotoxicology of Anthracycline Chemotherapeutics: TRANSLATING MOLECULAR MECHANISM INTO PREVENTATIVE MEDICINE Mol Interv June 2005 5:163-171; doi:10.1124/mi.5.3.6

N

  1. Norton, Stata

    • The Origins of Pharmacology in the 16th Century Mol Interv June 2005 5:144-149; doi:10.1124/mi.5.3.2

O

  1. O’Dowd, Brian F.

    • A G Protein–Coupled Receptor For Estrogen: The End Of The Search? Mol Interv June 2005 5:158-161; doi:10.1124/mi.5.3.5

P

  1. Peng, Xuyang

    • The Cardiotoxicology of Anthracycline Chemotherapeutics: TRANSLATING MOLECULAR MECHANISM INTO PREVENTATIVE MEDICINE Mol Interv June 2005 5:163-171; doi:10.1124/mi.5.3.6

S

  1. Sadée, Wolfgang

    • Pharmacogenomics: Harbinger for the Era of Personalized Medicine? Mol Interv June 2005 5:140-143; doi:10.1124/mi.5.3.1

  2. Sawyer, Douglas B.

    • The Cardiotoxicology of Anthracycline Chemotherapeutics: TRANSLATING MOLECULAR MECHANISM INTO PREVENTATIVE MEDICINE Mol Interv June 2005 5:163-171; doi:10.1124/mi.5.3.6

  3. Simmons, Mark A.

    • Functional Selectivity, Ligand-Directed Trafficking, Conformation-Specific Agonism: What’s In A Name? Mol Interv June 2005 5:154-157; doi:10.1124/mi.5.3.4

T

  1. Thummel, Kenneth E.

    • CYP3A Probes Can Quantitatively Predict the In Vivo Kinetics of Other CYP3A Substrates and Can Accurately Assess CYP3A Induction and Inhibition Mol Interv June 2005 5:151-153; doi:10.1124/mi.5.3.3

W

  1. Watkins, Paul B.

    • CYP3A Probes Can Quantitatively Predict the In Vivo Kinetics of Other CYP3A Substrates and Can Accurately Assess CYP3A Induction and Inhibition Mol Interv June 2005 5:151-153; doi:10.1124/mi.5.3.3

Current Issue

  1. April 2011, 11 (2)
  1. Current Issue
  1. Alert me to new issues of MI
Society Logo HighWire Press Logo CLOCKSS logo